Skip to main content
HCPCS J2561 · Level II · Part B drug

J2561: phenobarbital sodium (Sezaby), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: OPPS Addendum B: October 2026 (effective October 1, 2026); OPPS NDC-HCPCS crosswalk: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2561

Billing unit
1 MG
Inj, sezaby, 1 mg
OPPS payment rate
$0.038
no ASP limit; SI K, October 2026
Practitioner MUE
none published
CMS publishes no MUE for this code
OPPS status
SI K
APC 0798
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2561 is the Level II code for Injection, phenobarbital sodium (sezaby), 1 mg, billed per 1 MG. CMS publishes no ASP payment limit for it; hospital outpatient departments are paid separately under OPPS (status indicator K, $0.038 per billing unit in October 2026). With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. Other HCPCS codes whose descriptor names phenobarbital sodium: J2560 (the code whose CMS descriptor names no specific product; billed per 120 mg). The OPPS crosswalk maps 1 NDC to it, sold as Sezaby by Sun Pharmaceutical Industries, Inc. No current Billing and Coding Article lists J2561, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare payment: OPPS rate (no ASP limit)

J2561 does not appear in the October 2026 Part B ASP payment limit file. CMS pays it separately to hospital outpatient departments under OPPS with status indicator K in APC 0798, at a national unadjusted rate of $0.038 per 1 MG. Status K is a separately paid, non-pass-through drug or biological, including therapeutic radiopharmaceuticals. In a physician office the Medicare contractor prices the drug, often from invoice; commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 OPPS crosswalk maps 1 NDC from 1 labeler to J2561. Report the NDC in the claim's drug segment and bill the number of J2561 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.

NDCs that crosswalk to J2561
NDCDrug nameLabelerPackage sizeBilling units / package
62756-0301-01SezabySun Pharmaceutical Industries, Inc.1 × 1100

Medically Unlikely Edits (MUE)

CMS does not publish an MUE for J2561 in the 2026 Q4 tables. Some MUE values are confidential and applied without publication, so unit limits can still deny; document the dose and the units calculation on every claim.

MUE for J2561 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2561 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2561 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2561 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2561 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2561 carries status indicator K and is assigned to APC 0798, with a published national unadjusted payment of $0.038. Status K means the drug is paid separately under OPPS rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2561 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $0.04 per 1 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J2561 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2561

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2561

What does HCPCS code J2561 describe?

J2561 is defined by CMS as "Injection, phenobarbital sodium (sezaby), 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2561 a CPT code?

No. J2561 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as phenobarbital sodium (Sezaby); CPT codes are five-character codes maintained by the AMA. On a Part B claim J2561 reports the drug itself in 1 mg units, and the administration is billed on its own line.

What does Medicare pay for J2561 in a hospital outpatient department?

J2561 has no Part B ASP limit; the October 2026 OPPS Addendum B pays it separately under status K, APC 0798, at $0.038 per 1 MG, and ASC Addendum BB gives it payment indicator K2 at $0.04.

Which NDCs map to J2561?

The October 2026 OPPS crosswalk lists 1 NDC from 1 labeler: Sezaby (Sun Pharmaceutical Industries, Inc.). For example NDC 62756-0301-01 (package size 1) equals 100 billing units of J2561.

Does J2561 have NCCI bundling edits?

No active practitioner PTP pairs list J2561 as a column-1 or column-2 code in the v323r0 release.

J2561 vs J2560: what is the difference?

Both are HCPCS Level II codes whose descriptor names phenobarbital sodium. What sets J2560 apart: the code whose CMS descriptor names no specific product; billed per 120 mg. J2561 is billed per 1 mg, OPPS rate $0.038; J2560 is billed per 120 mg, limit $23.369, MUE 1. Report the code whose descriptor matches the product and setting in the record.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.